India POCT Market Outlook to 2023: Ken Research

1. India POCT Market Outlook to 2023 - By Major Devices (Blood Glucose Testing Kits, Infectious Disease Testing Kits, Blood Gas Electrolytes, Pregnancy and Fertility Testing Kits, Cardio Metabolic Monitoring, Anticoagulant Management, Cholesterol Testing Kits and Others), By End Users (Hospitals & Clinics, Consumers/ Individuals, Diagnostic Labs, Home Healthcare and Others), By Distribution Channel (Distributors and Direct Sales), By Consumables and Instruments and By Region May 2019

2. Table of Contents (1/2) 1. Executive Summary 1.1. Current Scenario 1.2. Future Projections 2. Research Methodology 2.1. Market Definitions 2.2. Abbreviations 2.3. Consolidated Research Approach 2.4. Variables (Dependent and Independent) 2.5. Correlation Matrix 2.6. Regression Matrix 2.7. Limitations and Conclusion 3. Value Chain Analysis of India POCT Market 3.1. Overview 3.2. Networking 4. Indian National Health Account Statistics 5. Market Overview and Genesis 5. 1. Market Time Line 6. India POCT Market Size- Current and Future Scenario 6.1. By Historical Revenue, FY’2013- FY’2018 6.2. By Forecasted Revenue, FY’2018- FY’2023 7. India POCT Market Segmentation- Current and Future scenario 7.1. By Major Devices (Blood Glucose Testing Kits, Infectious Disease Testing Kits, Blood Gas Electrolytes, Pregnancy and Fertility Testing Kits, Cardio Metabolic Monitoring, Anticoagulant Management, Cholesterol Testing Kits and Others), FY’2018- FY’2023E 7.1.1. Blood Glucose Testing Kits 7.1.2. Infectious Disease Testing Kits 7.1.3. Blood Gas Electrolytes 7.1.4. Pregnancy and Fertility Testing Kits 7.1.5. Cardio metabolic Monitoring 7.1.6. Anticoagulant Management 7.1.7. Cholesterol Testing Kits 7.1.8. Others 7.2. By End Users (Hospitals & Clinics, Consumers/ Individuals, Diagnostic Labs, Home Healthcare and Others), FY’2018- FY’2023E 7.3. By Consumables and Instruments, FY’2018-FY’2023E 7.4. By Distribution Channel (Distributors and Direct Sales), FY’2018 7.5. By Region (Tier 1, Tier 2 and Tier 3 Cities), FY’2018 and FY’2023E 8. Trends and Development of India POCT Market 2

3. Table of Contents (2/2) 9. Issues and Challenges of India POCT Market 10. Government Regulations for India POCT Market 10.1. Regulations for IVD Medical Devices 10.2. Regulatory Approval Process for Manufacture for Sale/Distribution of Medical Devices 10.3. Procedure to Apply for Import of Medical Devices 10.4. Fees and Charges for Medical Devices in India 10.5. List of Application Forms Required to Apply for Medical Devices Approval 10.6. List of Documents required with the Application for Grant of License to Manufacture or import of Medical Device 11. Trade Scenario of the India POCT Market 11.1. Import Value and Importing Countries, FY’2014-FY’2018 11.2. Export Value and Destinations of POCT Devices by India, FY’2014-FY’2018 11.3. Cross Comparison between Domestic Production and Import of POCT Devices (Major Products Manufactured in India, Major Imported Products, Major Manufacturers in India, Initiatives for manufacturing and others), FY’2018 11.4. Manufacturing Units of major POCT Device Manufacturers in India 12. Funding and Mergers and Acquisitions Scenario in the India POCT Market 13. Customer Decision Parameters in India POCT Market 14. Porter’s Five Forces in India POCT Market 15. Competition Landscape of India POCT Market 15.1. Competitive Scenario (Competing Parameters, Major Players and Competition Structure) 15.2. Market Share of Major Players - By Revenue, FY’2018 16. Strength and Weaknesses of Major Players in India POCT Market 17. Company Profiles of Major Players in India POCT Market including (Company Overview, Business Model, Strengths, Market Share, Key POCT Devices Offered, Total Income from All Brands, Financials, Mergers and Acquisitions and Product Profile) 17.1. Abbott India Limited 17.2. Roche Diagnostics 17.3. Siemens Healthcare Private Limited 17.4. Beckman Coulter India Pvt Ltd 17.5. J Mitra & co. Pvt. Ltd. 17.6. Trans Asia Bio Medical 17.7. Radiometer India 17.8. Bio Rad Laboratories 17.9. DiaSys India 17.10. Other Companies (EKF Diagnostics, Renesas Electronics, Triviton Healthcare Private Limited, Becton Dickinson India Private Limited and India Medtronic Private Limited) 18. Upcoming Technologies in India POCT Market 19. India POCT Market - Analysts Recommendations Disclaimer Contact Us 3

4. 1. Executive Summary

5. 1.1 Executive Summary (1/3) Figure 1.1: India POCT Market Size on the basis of Revenue in INR Crore and Growth Rate in Percentage (%), FY’2013- FY’2018 and FY’2023E 5,000.0 License Rights: Excel Only: USD 2000 Single User: USD 2500 Hard Copy: USD 3100 Single and Excel: USD 3500 Enterprise Wide: USD 5000 4,000.0 INR Crore 3,000.0 Slides: 152 2,000.0 Related Reports: 1,000.0 India Home Healthcare Market Outlook To 2023 - By Patient Profile (Elderly Care, Physiotherapy, Stroke Rehabilitation, Wound Care And Others); By Organized (Subscription And Non Recurring Model) And Unorganized, By Major Cities 0.0 FY' 2013 FY' 2018 FY' 2023E Source: Company Website, Ken Research Analysis 1 CAGR (FY’2013-FY’2018) : ~% India Diagnostic Laboratories Market Outlook To 2021 Growing Prevalence Of Diseases And Launch Of Technologically Advanced Procedures To Drive Growth 2 CAGR (FY’2018-FY’2023E) : ~% 3 Growing Stage Europe POCT Devices Market Outlook To 2022 - By Geography (Western Europe & Eastern Europe), By Product (Blood Glucose POCT, Infectious POCT, Cardiac POCT, Rapid Coagulation POCT, Blood Gas & Electrolytes POCT, Hematology POCT, Pregnancy POCT, Urinalysis POCT, Cholesterol POCT, Fecal Occult POCT, Hb1ac POCT & Drugs Of Abuse POCT), By Customer Segments (Hospitals & Clinics, Diagnostics Labs & Primary Care Units And Homecare & Patients) 4 Moderately Concentrated 5 Cost, Expertise, Brand, Ease of Use and Key Products Offered 5

6. 1.2. Executive Summary – Current Scenario Key Takeaways:  The India POCT Market is currently at its growing stage where new companies are setting up their units in the country. Figure 1.1: Flowchart for India POCT Market, FY2018 India POCT Market INR ~ Crores CAGR FY2013-FY2018 ~%  The India POCT market has witnessed an increased amount of investment and M&A activities. Market Structure: Moderately Concentrated By Consumables & Instruments INR ~ Crores By Major Devices INR ~ Crores By End Users INR ~ Crores Cardio metabolic Monitoring INR ~ Crores Blood Glucose Testing Kits INR ~ Crores Hospitals & Clinics INR ~ Crores Consumables INR ~ Crores  Since India is an emerging market for POCT device manufacturers, the lack of central laboratories drives the growth for these devices. Along with this, India constitutes of large rural communities and hence the incidences for infectious diseases are more. Consumer/Individuals INR ~ Crores Infectious Disease Testing Kits INR ~ Crores Anticoagulant Management INR ~ Crores Instruments INR ~ Crores Diagnostic Labs INR ~ Crores Blood Gas Electrolytes INR ~ Crores CAGR for Elderly Population ( FY2012- FY2017): ~% Cholesterol Testing Kits INR ~Crores Home Healthcare INR ~ Crores Pregnancy And Fertility Testing Kits INR ~ Crores  The elderly population in India have been increasing and hence there can be seen a need for handy rapid diagnosing devices which ensure faster treatment and a reduced number Others INR ~ Crores Others INR ~ Crores © This is a licensed product of Ken Research and should not be copied of hospital visits. 6

7. 1.3. Executive Summary - Future Projections Figure 1.2: Flowchart for Future Projection of India POCT Market, FY2018- FY2023E Key Takeaways:  The India POCT market is expected to grow at an enormous rate owing to factors such as compactness, portability and its usage by the non laboratory personnel in the purview of getting faster results. India POCT Market INR ~ Crores CAGR FY2018-FY2023E ~% By Consumables & Instruments INR ~ Crores By Major Devices INR ~ Crores By End Users INR ~ Crores  The major players operating in the market include Abbott's India, Roche Diagnostics, J Mitra & Co. Transasia Bio Medical, Bio Rad Laboratories, Siemens Limited, Radiometer India and others. Cardio metabolic Monitoring INR ~Crores Healthcare Private Hospitals & Clinics INR ~ Crores Blood Glucose Testing Kits INR ~ Crores Consumables INR ~ Crores CAGR Consumer/Individuals INR ~ Crores FY2017-FY2022E ~% Infectious Disease Testing Kits INR ~ Crores Anticoagulant Management INR ~ Crores Instruments INR ~ Crores  Launch of various new products in different product genre is anticipated to expand the target audience. penetration & higher number of smart phones users are likely to boost online sales in the country.  The growth in the POCT market is likely to be driven by more product acceptance by retail customers along with increased reliability and trust in the POCT devices by hospitals and as well as individuals. Diagnostic Labs INR ~ Crores Increasing internet Blood Gas Electrolytes INR ~Crores Cholesterol Testing Kits INR ~Crores Home Healthcare INR ~ Crores Pregnancy And Fertility Testing Kits INR ~ Crores Others INR ~ Crores Others INR ~ Crores 7 © This is a licensed product of Ken Research and should not be copied

8. 6. India POCT Market Size- Current and Future Scenario

9. 6.1. By Historical Revenue, FY’2013- FY’2018 Figure 6.1: India POCT Market Size on the basis of Revenue in INR Crore and Growth Rate in Percentage (%), FY’2013- FY’2018 Key Takeaways:  Increase in the Prevalence of Chronic Diseases: There has been an increase in the number of Acute Diseases amongst the Indian population in the recent years. Alongside this the prevalence of Chronic Illness such as Cancer has also been on a rise lately. The estimated cases of Cancer for the FY’2016 stood at ~ which grew to being ~ in the FY’2018. Increases of these diseases at such a large scale has pushed the use of POCT devices in India. One of the growth drivers for the POCT market also includes the elderly population in India which stood at ~ Millions in the FY’2018. The age specific chronic diseases such as Diabetes Mellitus has driven the sale of blood glucose testing kits.  The study, which provides the first-of-its-kind nationally representative estimates of cardiovascular mortality in India, shows that heart ailments caused more than 2.1 million deaths in India in 2015 at all ages, or more than a quarter of all deaths. At ages 30-69 years, of 1.3 million cardiovascular deaths, 0.9 million (68.4%) were caused by coronary heart disease and 0.4 million (28.0%) by stroke.  Advancement in Medical Knowledge and R&D: With major manufacturers noticing increase in per capita spending on healthcare by individuals, developing new and handy POCT methods/devices has been on rise. Mergers & Acquisitions, acquiring patents and high competition for market dominance has been prevalent.  Unease Associated with Laboratory Testing Methods: Easy & convenient managing of obesity and cardiovascular related diseases & fertility related issues, POCT devices have become a way out for people to get faster and cheaper detection method in comparison to cumbersome laboratory diagnostics. Pathology related diagnostics test have been performed at home with ease moreover, diagnostic lab test have become POCT-friendly, providing results within minutes. This has encouraged households to opt for these devices for early detection hence, early treatment.  New companies venturing the market: With vast scope of innovation and expansion, many new companies have been expanding their product lines into POCT device manufacturing. Witnessing highly profitable business associated with a successful new technology in POCT market, attracts new players. 10.2% 3,000.0 10.0% 2,500.0 9.8% 9.6% 2,000.0 INR Crore 9.4% Percentage (%) 1,500.0 9.2% 9.0% 1,000.0 8.8% 500.0 8.6% 8.4% 0.0 FY'2013 FY'2014 FY'2015 FY'2016 FY'2017 FY'2018 INR Crore Growth Rate (%) CAGR ~% During FY’2013- FY’2018 Overall Market Stage: ~ Total Number of Patients Suffering from stroke amount to ~ million in 2018 out of which (~%) were in the age range of 18-45 years 9 © This is a licensed product of Ken Research and should not be copied

10. 6.2. By Forecasted Revenue, FY’2018- FY’2023E Figure 6.2: India POCT Market Future Outlook and Projection on the basis of Revenue in INR Crore and Growth Rate in Percentage (%), FY’2018- FY’2023 Key Takeaways:  The India POCT market is expected to grow at an enormous rate owing to factors such as compactness, portability and its usage by the non laboratory personnel in the purview of getting faster results.  India has been a country with one of the highest number of Diabetic patients in the world and as per the International Federation of Diabetes, the numbers are likely to increase to ~ Million by 2025. Such alarming numbers have enabled the people to become proactive and keep a check on their Glucose levels, not just for treatment purposes but also as a preventive measure.  The elderly population in India is one of target end users for the home healthcare companies and overall POCT market in general. Increase in incidence of diseases such as HIV, Infectious and Cardiac will lead to strong growth of Infectious and Blood Glucose POCT devices.  Growth in POCT market in the country is most likely to be influenced by increase in the number of new entrants in the market, larger product acceptance by retail customers, increase in reliability & trust in POCT devices by home users & hospitals, expanding distribution channels and higher marketing expenditure by the companies.  Launch of various new products in different product genre is anticipated to expand the target audience. Increasing internet penetration & higher number of smart phones users are likely to boost online sales in the country.  Upcoming fields: Ocular Point-of-care, Traumatic Brain Injury (focused on developing POC for concussion management to assess the extent of brain damage following trauma), Rare Diseases (One example is a rapid POC device for sickle cell disease from Medomics), Neuropsychiatry Disorders detection (such as Alzheimer‘s, Schizophrenia), Molecular Diagnostics and Oncology (chemotherapy for disease progression using POC tests) 5,000.0 14.0% 4,500.0 12.0% 4,000.0 10.0% 3,500.0 Percentage (%) 3,000.0 8.0% INR Crore 2,500.0 6.0% 2,000.0 1,500.0 4.0% 1,000.0 2.0% 500.0 0.0 0.0% FY'2018 FY'2019 FY'2020 FY'2021 FY'2022 FY'2023 INR Crore Growth Rate (%) Future Projection of Market Stage: ~ CAGR ~% During FY’2018- FY’2023E Projected Elderly Population in India, FY’2023: ~ Million 10 © This is a licensed product of Ken Research and should not be copied

11. 7. India POCT Market Segmentation- Current and Future scenario By Major Devices By End Users By Consumables and Instruments By Distribution Channel By Region

12. 7.1. By Major Devices (Blood Glucose Testing Kits, Infectious Disease Testing Kits, Blood Gas Electrolytes, Pregnancy and Fertility Testing Kits, Cardio Metabolic Monitoring, Anticoagulant Management, Cholesterol Testing Kits and Others), FY’2018- FY’2023E Figure 7.1: India POCT Market Segmentation by Major Devices on the basis of Revenue (In Percentages), FY’2018-FY’2023E Table 7.1: India POCT Market Segmentation by Major Devices on the basis of Revenue (In INR Crore), FY’2018-FY’2023E POCT Device Market Basis Major Devices FY'2018E FY'2019E FY'2020E FY'2021E FY'2022E FY'2023E Blood Glucose Testing Kits ~ ~ ~ ~ ~ ~ Infectious Disease Testing Kits ~ ~ ~ ~ ~ ~ Blood Gas Electrolytes ~ ~ ~ ~ ~ ~ Pregnancy And Fertility Testing Kits ~ ~ ~ ~ ~ ~ Cardio metabolic Monitoring ~ ~ ~ ~ ~ ~ Anticoagulant Management ~ ~ ~ ~ ~ ~ Cholesterol Testing Kits ~ ~ ~ ~ ~ ~ Others ~ ~ ~ ~ ~ ~ The number of patients with diabetes mellitus is expected to reach ~ million in India and ~ million in China compared to ~million in U.S. by 2030. Total ~ ~ ~ ~ ~ ~ CAGR (FY2018- FY2023E) : ~% for Blood Glucose Testing 12 © This is a licensed product of Ken Research and should not be copied

13. 7.1.1. Blood Glucose Testing Kits (1/2) Table 7.2: Blood Glucose POCT Devices Market Segment Including Product Overview, Test Purpose, Instrument & Consumable, Market Size, Market Future, Major Companies, Major Brands and Key Weakness Parameters Description • ~ Product Overview • ~ Test Purpose • ~ Instrument & Consumable • ~ Market Size & Related Numbers • ~ Market Future •~ Major Companies •~ Major Brands • ~ Key Weakness 13 © This is a licensed product of Ken Research and should not be copied

14. 7.1.1. Blood Glucose Testing Kits (2/2) Key Strengths  In the India POCT Glucose • Turn Around Time: Refers to the total period from a clinician’s issuance and delivery order, collection, analysis of calculation, verification and delivery of results to review of results. A undisputed advantage of POCT for BG is the rapid turn-around time compared to CLT. POCT gives results in ~ minutes while in CLT, it takes ~ minutes. • Patient Sample Volume: POCT devices utilize very small volume of blood, ~ µL, in contrast to CLT requiring ~ mL of blood. For blood conservation in patients, it is advisable to use POCT Devices as the mean volume of blood loss per patient per admission due to POCT for BG is only ~ ml however in CLT blood loss per patient per admission due to phlebotomy is between ~ and ~ mL (ICU: Between 600- 700 mL). • Common Issues with CLT: Mislabeling patient sample, sample, Contamination sample, Degradation of sample due to delay in either transport or processing of sample after arrival at the laboratory and others. market, Testing kits had the highest share of ~% for the FY2018. This testing kit is a device used on a routine basis to monitor glucose levels for people at home patients under glycemic requirements. Blood  This high share owes to the fact that number of people suffering from Mellitus have increased from being ~ Million in the year 2013 to ~ Million in the year 2017. Hence more number of people are opting for such monitoring devices. of transportation specimen and and Diabetes or for tight control KEY FACTS  Type II Diabetes is ~ to ~ times more prevalent in urban areas as compared to the rural areas factors obesity, insulin resistance and lifestyle changes owing to urbanization. due to such as Lost of 14 © This is a licensed product of Ken Research and should not be copied

15. 7.1.2. Infectious Disease Testing Kits Table 7.3: Infectious POCT Devices Market Segment Including Product Overview, Instrument & Consumable, Major Players, Market Size, Market Future, Major Brands, Growth Strategies and Technologies Parameters Description • ~ Product Overview • ~ Instrument & Consumer-able • ~ Major Players • ~ Market Size & Numbers • ~ Market Future • ~ Major Brands • ~ Company Growth Strategies • ~ Technologies 15 © This is a licensed product of Ken Research and should not be copied

16. 7.1.3. Blood Gas Electrolytes Table 7.4: Blood Gas Electrolytes Market Segment Including Product Overview, Instrument & Consumable, Replacement Time, Market Size, Market Future and Major Players Parameters Description • ~ Product Overview • ~ Instrument & Consumable • ~ Replacement Time • ~ Market Size • ~ Market Future Major Players • ~ 16 © This is a licensed product of Ken Research and should not be copied

17. 7.1.4. Pregnancy and Fertility Testing Kits Table 7.5: Pregnancy And Fertility Testing Kits Market Segment Including Segment Overview, Product Details and Instrument & Consumer-able, Major Players, Major Products, Product related difficulties faced by the consumers, Market Size and Market Future Parameters Description • ~ Segment Overview • ~ Product Details and Instrument & Consumer-able • ~ Major Players • ~ Major Products • ~ Market Size & Related Numbers • ~ Market Future • ~ Product related difficulties faced by the consumers 17 © This is a licensed product of Ken Research and should not be copied

18. 7.1.5. Cardio metabolic Monitoring Table 7.6: Cardio metabolic Monitoring POCT Devices Market Segment Including Product Overview, Instrument & Consumable, Current Market Trends, Major Players, Market Size, End Users, Major Customers and Future Market Size Parameters Description Product Overview • ~ • ~ Current Trends Instrument & Consumable • ~ • ~ Market Size & Related Numbers • ~ Market Future • ~ Major Customers • ~ Major Players Key End-user Groups • ~ 18 © This is a licensed product of Ken Research and should not be copied

19. 7.1.6. Anticoagulant Management Table 7.7: Anticoagulant Management POCT Devices Market Segment Including Segment Overview, Key Strengths, Major Players, Major Products, End Users, Market Size & Related Numbers and Market Future Parameters Description • ~ Segment Overview • ~ Strengths • ~ End Users • ~ Market Size & Related Numbers • ~ Market Future • ~ Major Players • ~ Major Products 19 © This is a licensed product of Ken Research and should not be copied

20. 7.1.7. Cholesterol Testing Kits Table 7.8: Cholesterol Testing Kits Market Segment Including Product Overview, Instruments and consumables, Major Players, Leading Product, Market Size & Related Numbers and Market Future Parameters Description • ~ Product Overview Instrument & Consumable • ~ • ~ Market Size & Related Numbers • ~ Market Future Major Players • ~ Cholesterol Testing Kits: ~% CAGR 20 © This is a licensed product of Ken Research and should not be copied

21. 7.1.8. Others Table 7.9: Other Products Market Segmentation Including HbA1c, Drug of Abuse Testing Kits, Urinalysis Testing Kits and Fecal Occult Testing Kits. Parameters Description • ~ HbA1c Drug of Abuse Testing Kits • ~ • ~ Urinalysis Testing Kits • ~ Fecal Occult Testing Kits 21 © This is a licensed product of Ken Research and should not be copied

22. 7.2. By End Users (Hospitals & Clinics, Consumers/ Individuals, Diagnostic Labs, Home Healthcare and Others), FY’2018- FY’2023E (1/2) Figure 7.2: India POCT Market Segmentation by End Users on the basis of Revenue (in Percentages), FY’2018-FY’2023E Table 7.11: Cross Comparison of POCT Devices on the Basis of End Users Including Key Users, Revenue Generated & Others Customers and Individuals (B2C) Diagnostics Labs & Primary Care Units (B2B) Hospitals & Clinics (B2B) Parameter Key Users ~ ~ ~ Revenue Generated (INR Million), FY’18 ~ ~ ~ POCT Devices Used ~ ~ ~ Table 7.10: India POCT Market Segmentation by End Users on the Basis of Revenue (in INR Crore), FY’2018-FY’2023E POCT Device Market Basis End Users FY'2018 FY'2019E FY'2020E FY'2021E FY'2022E FY'2023E Purpose of Devices ~ ~ ~ ~ ~ ~ ~ ~ ~ Hospitals & Clinics ~ ~ ~ ~ ~ ~ Consumer/Individuals ~ ~ ~ ~ ~ ~ Diagnostic Labs Usual Tests Done For ~ ~ ~ ~ ~ ~ ~ ~ ~ Home Healthcare ~ ~ ~ ~ ~ ~ Others ~ ~ ~ ~ ~ ~ Total Technology Used ~ ~ ~ 22 © This is a licensed product of Ken Research and should not be copied

23. 7.2. By End Users (Hospitals & Clinics, Consumers/ Individuals, Diagnostic Labs, Home Healthcare and Others), FY’2018- FY’2023E (2/2) The hospitals and clinics are expected to grow at a CAGR of 11.0% for the period of FY2018- FY2023E and are expected to generate a revenue of INR 3600.0 Million from the POCT segment. The number of primary health centers operating in India as of FY2018 stands at 25,743 and the ones operating as per the IPHS norms are 3,052. These numbers are not sufficient to cater the increasing Indian population which is expected to be 1,365,302 for FY2023 and simultaneously the number of patients have also been on a rise. This serves as a growth driver for all the hospitals and clinics providing POCT solutions. Hospitals and Clinics The segment for consumers and individuals is expected to grow at a CAGR of 12.6% for the period of FY2018- FY2023E and is expected to generate a revenue of INR 4,477.7 Million for the FY2023. The growth drivers for the same includes the lifestyle changes inculcated by the individuals as they have become more proactive in nature. Individuals have been using POCT devices such as Cholesterol testing as a precautionary measure in order to prevent various cardiac diseases. Individuals are also considering genetic disorders and are using POCT devices as a move in the process of becoming health conscious. Consumers and Individuals The diagnostic laboratories are expected to grow at a CAGR of 7.0% for the period of FY2018- FY2023E and the revenue generated by them form the POCT segment is valued at INR 1053.6 Million. There has been a significant increase in the number of people suffering from cancer in India wherein the number stood at 1,451,417 in the FY2016 and grew to 1,586,571 in the FY2018. The treatment for cancer requires certain tests which have to be conducted and those are facilitated by these diagnostic labs. A total of 95 (approx.) NABL accredited diagnostic labs are prevailing in India. Diagnostic Labs The Home Healthcare segment is expected to grow at a CAGR of 18.5% for the period of FY2018- FY2023E and are expected to generate a revenue of INR 1,053.6 Million for the FY2023. This growth has been one of the highest amongst all the considered segments due to various growth drivers which include the need for elderly care, Stroke patients, post ICU care, post surgery care, mother and child care. The home healthcare market in India is dominated by the unorganized sector contributing INR 17,004.8 Crores, with an overall share evaluated at 80% of the total market size. It can be seen as an emerging segment as its still in its early growth stage and major players are still working on establishing their presence in major cities. Home Healthcare 23 © This is a licensed product of Ken Research and should not be copied

24. 7.3. By Consumables and Instruments, FY’2018-FY’2023E (1/2) Figure 7.3: India POCT Market Segmentation by Consumables and Instruments on the basis of Revenue in Percentage (%), FY2018- FY2023E Table 7.13: Cross comparison on the Basis of Consumables and Instruments including Definition, Rationale and Average Replacement Rate, Components included, Highest Product Category Usage Parameter Instruments Consumables Definition ~ ~ Table 7.12: India POCT Market Segmentation by Consumables and Instruments on the basis of Revenue for the Period of FY2018- FY2023 (in INR Crore), FY’2018-FY’2023E Rationale and Average Replacement Rate ~ ~ Consuma bles and Instrumen ts FY'2018 FY'2019E FY'2020E FY'2021E FY'2022E FY'2023E Consumab les (cartridge s, test strips etc.) Components included ~ ~ ~ ~ ~ ~ ~ ~ Highest Product Category Usage Instrumen ts (Main Device) ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ Total 24 © This is a licensed product of Ken Research and should not be copied

25. 7.3. By Consumables and Instruments, FY’2018-FY’2023E (2/2) Table 7.14: List of POCT products manufactured by Alere, Abbott Ltd. And Roche Diagnostics Limited Including Company, Best Seller Product, Diagnosed Product Category and Instrument and Consumables Used Product (Best Seller) Company Diagnosed Product Category Instrument & Consumable Used ~ Alere ~ ~ ~ Alere ~ ~ ~ ~ Abott ~ ~ ~ ~ Alere ~ ~ ~ ~ ~ ~ Roche ~ ~ Roche ~ ~ ~ ~ Roche ~ ~ 25 © This is a licensed product of Ken Research and should not be copied

26. 7.4. By Distribution Channel (Distributors and Direct Sales), FY’2018 Figure 7.4: India POCT Market Segmentation by Distribution Channel on the basis of Revenue in Percentage, FY’2018 ~ in 2018 Number of Pharmacies ~ in 2016 ~ in 2014 Key Takeaways:  Distributors: They play a key role in the overall POCT market in India constituting ~% of market share on the basis of revenue as of FY2018. The share of distributors include the distributors for end users and for retailers as well. The end users include the hospitals and clinics, diagnostic labs, individuals and home healthcare companies. These users conduct the POCT business on a large scale and in order to cater to such big clients, the POCT companies prefer to sell their devices through distributors. Alongside catering to these end users, POCT companies sell their devices through distributors to retailers such as small scale pharmacies. There were ~ pharmacies in India as of FY2018.  Margin of the distributors: The distributor’s margin on the sale of consumables is valued at around ~% to ~% and the margin on the sale of instruments is valued at ~% to ~%.  Major Distributors: The major distributors in the India POCT market include BHR Diagnostics Pvt. Ltd.,  Direct Sale: The direct sale of POCT devices constitute only ~% of the market share on the basis of revenue in FY2018. Majority of the POCT companies do not contact their clients directly and rather prefer using a medium to sell their products due to the high cost involved. It has also been observed that the companies might face difficulties while entering to new markets if they use direct sales over distributors. This corresponds to the fact that the major companies providing POCT devices in India have their origins in different other countries and in order to cater to the Indian market they choose to sell through distributors. Table 7.15: India POCT Market Segmentation by Distribution Channel on the Basis of Revenue in INR Million, FY’2018 Distribution Channel FY' 2018 Through Distributors to end users ~ Through Distributors to retailers Directly ~ 26 © This is a licensed product of Ken Research and should not be copied

27. 7.5. By Region (Tier 1, Tier 2 and Tier 3 Cities), FY’2018 and FY’2023E Figure 7.5: Market Segmentation and Future Projection by Region on the basis of Sales of POCT Devices in Tier 1, Tier 2 and Tier 3 Cities of India in Percentage (%), FY2018 and FY’2023E Key Takeaways:  The segmentation of the India POCT market by regions is based on the tier 1, tier 2 and tier 3 cities of India. Tier 1 city includes the metro cities of the country including Delhi/NCR, Mumbai, Hyderabad, Bangalore, Chennai, and Kolkata.  The sale of POCT devices is the highest in Tier 1 cities followed by tier 2 cities owing to the factor that the country’s major Multi Specialty and Single Specialty hospitals are located in these cities and people from all over India visit them for accessing specialized treatment.  The people residing in tier 1 and tier 2 cities have a higher personal disposable income as compared to other cities. Furthermore, the people in tier 1 cities are more aware about such devices and have an easy access to them.  The sales of POCT devices is the highest in Delhi followed by Chennai as these are the hub for medical care patients. The country’s topmost Multi Specialty and Super Specialty Hospitals are located in these cities including Apollo Specialty Hospital in Chennai and All India Institute of Medical Sciences (AIIMS) in Delhi. POCT devices for diseases such as Cardiac diseases, stroke and diabetes are not only used by these hospitals but also by the patients visiting these hospitals for varied treatments in order to conduct regular self checkups.  It has also been observed that the diseases, Diabetes, high Cholesterol and stroke are more in the urban areas of India owing to the lifestyle changes. Perhaps, this has encouraged the sales of POCT devices as people have started using POCT devices for regular self check-ups as well.  Furthermore, it has been anticipated that the sale of POCT devices would reduce in Tier 1 cities and in turn the sales would increase in the Tier 3 cities. The reasons behind this paradigm shift could possibly include the increasing awareness and government initiatives for improving the rural healthcare in Tier 3 cities. For instance, one of the government’s program named as ‘Ayushman Bharat’ for rural healthcare betterment could seek more traction in the near future.  The private companies entering the India POCT market have already started setting up their manufacturing units in Tier 2 and Tier 3 cities of India. For instance, companies such as Becton Dickinson India, Boston Scientiic Corp and others have set up their manufacturing units in various areas of Haryana and Chandigarh. incidence of diseases such as Cardiac Table 7.16: Market Share (Estimated) of Each City under Tier 1 in Percentage (%), FY’2018 City Market Share of Tier-1 cities (in %), FY2018 ~ Delhi/NCR ~ Chennai ~ Mumbai ~ Bangalore ~ Hyderabad ~ Kolkata ~ Total 27 © This is a licensed product of Ken Research and should not be copied

28. 15. Competition Landscape of India POCT Market

29. 15.1. Competitive Scenario (Competing Parameters, Major Players and Competition Structure) Cost Key Metrics of India POCT Market Expertise ~ ~% Market Stage CAGR 2013-2018 Brand ~ ~ Ease of Use Competitive Structure Number of Companies operating © This is a licensed product of Ken Research and should not be copied 29

30. 15.2. Market Share of Major Players - By Revenue, FY’2018 Table 15.1: Market Share of Major Players Operating in the India POCT Market on the Basis of Revenue in Percentage (%), FY’2018 Key Takeaways: Major Players Revenue Share (in %), FY’2018  The key players in the India POCT market include Abbott India Limited, Roche Diagnostics Healthineers, Johnson & Johnson, J Mitra & Co. Pvt. Ltd. and companies under Danaher Corporation operating in India.  Taking into consideration the diversity of the POCT products offered in this segment, there is no clear industry leader. However, companies specialize in some particular sub segments.  The total number of companies operating in the market exceed ~ in numbers. Although more than half of he market is covered by the major players existing in the market.  There are more number of international players dominating the India POCT market including Abbott, Danaher Corporation, Beckman Coulter and others. Companies have started setting up their manufacturing units in India as well.  The market share of other companies constitute a large amount of 28.0% to 43.0% for the FY2018 as the market structure of the industry is moderately concentrated.  Other companies include Diagnostics, Renesas Electronics , Avalun , Wersen ,S D Biocenter, Trivitron Healthcare Pvt Ltd, Becton Dickinson India Pvt Ltd and others. ~ Limited, Siemens Abbott's India/ Alere India ~ Roche Diagnostics ~ Danaher Corporation J Mitra & Co. ~ Transasia Bio Medical ~ Bio Rad Laboratories ~ companies such as ~ Siemens Healthcare Private Limited ~ Beckman Coulter India Pvt Ltd Hemocue, Atomo Diasys India ~ ~ Others 30 © This is a licensed product of Ken Research and should not be copied

31. 17. Company Profiles of Major Players in India POCT Market Abbott India Limited Roche Diagnostics Siemens Healthcare Pvt. Ltd. Beckman Coulter India Pvt. Ltd. J Mitra & Co. Pvt Ltd. Trans Asia Biomedical Radiometer India Bio Rad Labratories DiaSys India Others

32. 17.1. Abbott India Limited (1/3) Table 17.1: Company profile of Abbott India Limited including Company Overview, Business Model, Strengths, Market Share, Key POCT Devices Offered and Mergers & Acquisitions Parameters Description • Company Overview ~ • Business Model ~ • ~ Strengths • ~ Market Share • ~ Key POCT Devices Offered 32 © This is a licensed product of Ken Research and should not be copied

33. 17.1. Abbott India Limited (2/3) Figure 17.1: Total Income of Abbott India Limited from All its Brands, FY’2015 - FY’2017 Table 17.2: Financials of Abbott India Limited (in INR Million), FY2015, FY2016 and FY2017 40,000.00 Parameters FY’15 FY’16 FY’17 30,000.00 INR Million Revenue from Operations ~ ~ ~ Other Income Total Income ~ ~ ~ ~ ~ ~ 20,000.00 10,000.00 Total Expenses ~ ~ ~ 0.00 EBITA ~ ~ ~ FY'2015 FY'2016 FY'2017 PAT ~ ~ ~ Table 17.1: Company profile of Abbott India Limited including Company Overview, Business Model, Strengths, Market Share, Key POCT Devices Offered and Mergers & Acquisitions Parameters Description • ~ • ~ Mergers and Acquisitions 33 © This is a licensed product of Ken Research and should not be copied

34. 17.1. Abbott India Limited (3/3) Table 17.3: Product Portfolio of Blood Glucose Monitoring Systems of Abbott India Limited FreeStyle Freedom Lite FreeStyle InsuLinx FreeStyle Precision Neo Parameters FreeStyle Lite • • • • Description ~ ~ ~ ~ • • • • Sample Size ~ ~ ~ ~ • • • • Fast Test Time ~ ~ ~ ~ • • • • Display ~ ~ ~ ~ • • • • Meter Size ~ ~ ~ ~ • • • • Alarms ~ ~ ~ ~ • • • • Ability to Reapply Blood ~ ~ ~ ~ • • • • Test Strip Port Light ~ ~ ~ ~ • • • • Backlight ~ ~ ~ ~ • • • • Alternate Site Testing ~ ~ ~ ~ • • • • Battery Life ~ ~ ~ ~ • • • • Meter Memory ~ ~ ~ ~ © This is a licensed product of Ken Research and should not be copied 34

35. Disclaimer The research reports provided by Ken Research are for the personal information of the authorized recipient and is not for public distribution and should not be reproduced or redistributed without prior permission. None of this material may be used for any commercial or public use until unless authorized by Ken Research. The report will only be used as per the license rights authorized by Ken Research. The information provided in the research documents is from publicly available data and other sources, which are reliable. Efforts are made to try and ensure accuracy of data. With respect to documents available, neither the company nor any of its employees makes any warranty, express or implied, including the warranties of merchantability and fitness for a particular purpose, or assumes any legal liability or responsibility for the accuracy, completeness, or usefulness of any information, apparatus, product, or process disclosed, or represents that its use will not infringe privately owned rights. The report also includes analysis and views expressed by our research team. The research reports are purely for information purposes. The opinions expressed are our current opinions as of the date appearing in the material and may be subject to change from time to time without notice. Investors should not solely rely on the information contained in the research documents and must make investment decisions based on their own investment objectives, risk profile and financial position. The recipients of this material should take their own professional advice before acting on this information. Ken Research will not accept returns of reports once dispatched due to the confidentiality of information provided in our reports. In case, a report qualify for return, we will issue a credit, minus shipping charges, of equal value to the original purchase price, toward a future purchase—no refunds. The decision about whether the product return can be accepted or not is solely at our discretion. Any dispute will be subject to laws of India and exclusive jurisdiction of Indian Courts. No part of this manual or any material appearing may be reproduced, stored in or transmitted in any other format without written permission of Ken Research. This is purely for the reference of the concerned entity. 35 © This is a licensed product of Ken Research and should not be copied

36. CONTACT US Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, Sector 49, Gurgaon, Haryana - 122001 Contact Us Office: +91 9311149880 Web: www.kenresearch.com Email: namit@kenresearch.com 36